Intelligent Bio Solutions (INBS) received a U.S. patent for its fingerprint drug screening technology, expanding its ...

Company’s 6th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology Patent protection strengthens Company’s competitive position as it prepares for planned ...

Building the world's largest biobank with data from global populations to accelerate biomarker and drug discovery and ...

Company to Host Conference Call Today, March 27, at 4:30pm ETBOCA RATON, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and ...

“The NDASA conference brings together key voices in workplace drug testing,” said Daniel Brown, Head of Clinical Affairs at Intelligent Bio Solutions.“We’re proud to support its mission and contribute ...

Intelligent Bio Solutions (INBS) announced that the Company has been granted a patent in the United States relating to its Intelligent ...

The Vietnam Bio-based Polypropylene in Medical Devices Market was valued at USD 157.44 thousand in 2024 and is projected to reach USD 377.41 thousand by 2033, growing at a CAGR of 15.64% during the ...

A passport becomes invalid if it is damaged beyond repair, so it is important to keep it in order. Here are examples of what ...

On December 18, 2024, the Company announced the submission of its 510 (k) premarket notification to the U.S. Food and Drug Administration (FDA) for review and clearance of its Intelligent ...

Belite Bio Inc (NASDAQ: BLTE) stock falls after reporting Q3 net loss of $36.1M; analysts maintain Buy/Overweight rating, citing positive trial results.

Company's 6th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology Patent protection strengthens Company's competitive position as it prepares for planned ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...